Artiva Biotherapeutics, Inc. (ARTV) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ARTV…

Artiva Biotherapeutics, Inc. (ARTV) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Artiva Biotherapeutics, Inc.

ARTV · CIK 1817241

4 · Oct 7, 2026 · Director, Chief Executive Officer Aslan Fred sold 23.46K shares at $7.20/share ($168.9K)

4

Director, Chief Executive Officer Aslan Fred sold 23.46K shares at $7.20/share ($168.9K)

Filed: Oct 7, 2026
Period: Oct 6, 2026
Accession: 0001193125-26-416953
Filer: Artiva Biotherapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov